Neurogene, Inc. (NGNE)
20.92
-0.34
(-1.60%)
USD |
NASDAQ |
Dec 12, 16:00
20.95
+0.03
(+0.14%)
After-Hours: 20:00
Neurogene Total Liabilities (Quarterly): 22.29M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| Verastem, Inc. | 192.38M |
| Anavex Life Sciences Corp. | 8.946M |
| Coherus Oncology, Inc. | 428.74M |
| Ocugen, Inc. | 54.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.83M |
| Shareholders Equity (Quarterly) | 265.54M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 18.37 |
| Net Debt Paydown Yield | 0.28% |